Efficacy and Safety of JAK Inhibitors in Treating Lichen Planopilaris or Frontal Fibrosing Alopecia
February 2025
in “
Journal of the European Academy of Dermatology and Venereology
”
Studysummary This study suggests that Janus kinase inhibitors may offer a potential treatment option for refractory lichen planopilaris and frontal fibrosing alopecia, showing positive response rates between 42% and 100%, though evidence quality is low.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →